cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Jazz Pharmaceuticals Plc
23 own
22 watching
Current Price
$110.58
$-2.91
(-2.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
8,794.7M
52-Week High
52-Week High
147.45000
52-Week Low
52-Week Low
110.42000
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
199.9066
iconMarket Capitalization8,794.7M
icon52-Week High147.45000
icon52-Week Low110.42000
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio199.9066
What does the Jazz Pharmaceuticals Plc do?
Jazz Pharmaceuticals Public Limited Company, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. It markets Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia (ALL); Defitelio for the treatment and prevention of severe hepatic veno-occlusive disease, a potentially life-threatening complication of hematopoietic stem cell transplantation; and Prialt, an intrathecally administered infusion of ziconotide for the management of severe chronic pain. The company also develops JZP-110, which is in phase III clinical trial for the treatment of excessive sleepiness (ES) in patients with narcolepsy and obstructive sleep apnea, as well as phase II clinical trial for ES associated with Parkinson's disease; Vyxeos (CPX-351) for high-risk acute myeloid leukemia; and JZP-507 and JZP-258 to treat EDS and cataplexy in narcolepsy, as well as evaluates deuterated oxybate for narcolepsy. In addition, it sells psychiatry and other products. The company is headquartered in Dublin, Ireland.
Read More
How much money does Jazz Pharmaceuticals Plc make?
News & Events about Jazz Pharmaceuticals Plc.
Globe Newswire
9 months ago
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board Zug, Switzerland & Egham, UK 21 June 2023 Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products...
Ticker Report
10 months ago
Jazz Pharmaceuticals plc (NASDAQ:JAZZ Get Rating) has received an average recommendation of Buy from the nine ratings firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy ...
Ticker Report
12 months ago
Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ Get Rating) by 0.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 176,388 shares of the ...
Zolmax
1 year ago
Pinnacle Associates Ltd. cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ Get Rating) by 1.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,375 shares of the specialty pharmaceutical companys stock after selling 100 shares during the ...
Ticker Report
1 year ago
Jazz Pharmaceuticals (NASDAQ:JAZZ Get Rating) had its target price boosted by The Goldman Sachs Group from $190.00 to $212.00 in a research report report published on Friday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the specialty pharmaceutical company...
Frequently Asked Questions
Frequently Asked Questions
What is Jazz Pharmaceuticals Plc share price today?
plus_minus_icon
Can Indians buy Jazz Pharmaceuticals Plc shares?
plus_minus_icon
How can I buy Jazz Pharmaceuticals Plc shares from India?
plus_minus_icon
Can Fractional shares of Jazz Pharmaceuticals Plc be purchased?
plus_minus_icon
What are the documents required to start investing in Jazz Pharmaceuticals Plc stocks?
plus_minus_icon
What is today’s traded volume of Jazz Pharmaceuticals Plc?
plus_minus_icon
What is today’s market capitalisation of Jazz Pharmaceuticals Plc?
plus_minus_icon
What is the 52-Week High and Low Range of Jazz Pharmaceuticals Plc?
plus_minus_icon
What percentage is Jazz Pharmaceuticals Plc down from its 52-Week High?
plus_minus_icon
What percentage is Jazz Pharmaceuticals Plc up from its 52-Week Low?
plus_minus_icon
Current Price
$110.58
$-2.91
(-2.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00